SMTL ID : 4m7i.1

Crystal Structure of GSK6157 Bound to PERK (R587-R1092, delete A660-T867) at 2.34A Resolution

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.34 Å

Oligo State

monomer

Ligands

1 x 27D: 1-[5-(4-amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-4-fluoro-1H-indol-1-yl]-2-(6-methylpyridin-2-yl)ethanone(Non-covalent)

27D.1: 17 residues within 4Å: Chain A: L.13, V.21, A.34, K.36, L.57, A.58, V.66, Y.68, I.92, M.94, Q.95, L.96, C.97, F.150, G.160, D.161, F.162 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:A.34, A:K.36, A:L.57, A:V.66, A:Y.68, A:Y.68, A:Y.68, A:I.92, A:D.161, A:F.162 Hydrogen bonds: A:Q.95, A:C.97

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Axten, J.M. et al., Discovery of 5-{4-fluoro-1-[(6-methyl-2-pyridinyl)acetyl]-2,3-dihydro-1H-indol-5-yl}-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2656157), a Potent and Selective PERK Inhibitor Selected for Preclinical Development. To be Published

Release Date

2014-09-03

Peptides

Eukaryotic translation initiation factor 2-alpha kinase 3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Eukaryotic translation initiation factor 2-alpha kinase 3

Related Entries With Identical Sequence